AstraZeneca Purchases 692,000 SF Amgen Facility in Longmont

View here

AstraZeneca, a global, science-led biopharmaceutical firm, spent $64.5M on a manufacturing plant that sits on a 228-acre site in Longmont from Amgen, Inc.

Image extracted from AstraZeneca R&D Image Library